HrishikeshKumarBelaniMDMPH, AAHIVS(He/Him)
Internal Medicine • Los Angeles, CAAddiction Medicine, HIV/AIDS Medicine
Primary Care Director, Ambulatory Care Network, LA County Health Services l Assisted Professor, UCLA David Geffen School of Medicine
Dr. Belani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
South Los Angeles Health Center Group
5850 S. Main St
Los Angeles, CA 90003
Summary
- Dr. Hrishikesh Belani is an internist in Los Angeles, CA and is affiliated with Los Angeles Community Hospital at Los Angeles. He received his medical degree from University of Minnesota Medical School and has been in practice 0 years. He specializes in addiction medicine and hiv/aids medicine and is experienced in hiv/aids, healthcare administration, healthcare quality, operations, and ambulatory medicine. He has more than 10 publications and over 300 citings.
Education & Training
University of ColoradoResidency, Internal Medicine, 2013 - 2016
University of Minnesota Medical School
Certifications & Licensure
CA State Medical License 2016 - 2025
CO State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Academy of HIV MedicineHIV Specialist
Clinical Trials
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) Start of enrollment: 2021 Jan 01
- ACTIV-6: COVID-19 Study of Repurposed Medications Start of enrollment: 2021 Jun 08
- Collaboration Leading to Addiction Treatment and Recovery From Other Stresses Start of enrollment: 2021 Jan 08
Publications & Presentations
PubMed
- 5 citationsFavorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, Amy B Karger, David J Odde
Clinical Infectious Diseases. 2024-08-16 - A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment.Katrina M Hartman, Barkha Patel, Via Rao, Aubrey A Hagen, Hanna G Saveraid
Open Forum Infectious Diseases. 2024-07-01 - 70 citationsOutpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase...Carolyn T Bramante, John B Buse, David M Liebovitz, Jacinda M Nicklas, Michael A Puskarich
The Lancet. Infectious Diseases. 2023-10-01
Journal Articles
- Gout of the Ordinary: A Case of Clavicular Gout in HIVJay Thetford, MD, Poonam Manwani, MD, Emil Heinze, MD and Hrishikesh Belani, MD, Proceedings, Department of Medicine - UCLA, 2/3/2021
Authored Content
- Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19August 2022
Grant Support
- ACCT-AD Toolkit implementation for Diagnosis of Dementia in Primary Care Practice (AIDD-PCP)State of California2020–2025
- Addiction Treatment Starts HereCenter for Care Innovations2019–2021
- Innovation CatalystCenter For Care Innovations2017–2018
Research History
- Sub-award PI/ ACCT-AD Toolkit implementation for Diagnosis of Dementia in Primary Care Practice (AIDD-PCP)The AIDD-PCP program is a state-funded initiative led by UCSF. The goal of this implementation grant is to train adult primary care providers/staff to use the ACCT- AD toolkit to diagnose dementia in patient, and determine the efficacy of the toolkit.2020 - 2025
Professional Memberships
- Society for General Internal MedicineMember
- American Academy for HIV MedicineMember
Industry Relationships
- Advisor, Sunnyside2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
